UK leaders push for 18-week dementia target to match cancer care

Key points

• The Alzheimer’s Society and The King’s Fund have proposed an 18-week referral-to-treatment target for dementia, similar to existing NHS cancer standards.
• Prime Minister Andy Burnham has committed to appointing a senior official to oversee dementia care and release a modern service framework by the end of 2026.
• Baroness Louise Casey, leading a major social care review, has backed the proposal, urging the government to treat dementia with the same urgency as cancer.
• The report highlights that dementia care lacks the sustained political leadership and unified movement that drove improvements in cancer treatment over the past two decades.
• Approximately 1 million people in the UK currently live with dementia, a figure expected to rise to 1.4 million by 2040, with many patients reporting feeling abandoned after diagnosis.

Background

This push for reform follows Prime Minister Andy Burnham’s personal experience with his father’s Alzheimer’s disease, which he cited as a driver for his broader pledge to reform adult social care in England. Earlier in 2026, Burnham outlined a vision for a national care service, aiming to address long-standing issues in the sector. The current debate builds on previous commitments to improve dementia support, which have often lacked the consistent momentum seen in other health priorities.

How outlets are covering it

The BBC reports that Social Care Minister Alison McGovern supports the new report, describing dementia as 'neglected for far too long' and acknowledging the sharp division between health and social care. In contrast, The King’s Fund and Alzheimer’s Society emphasize that while scientific advances in dementia treatment are promising, the current system is not ready to deliver them, citing workforce shortages and fragmented services. The Yorkshire Post highlights the emotional toll on families, noting that dementia is the UK’s biggest killer yet lacks the clear pathways and hope associated with cancer care. While The i Paper notes potential improvements in access to new dementia drugs like lecanemab through cost-effectiveness changes, it does not address the broader systemic waiting-time targets proposed by the Alzheimer’s Society. All sources agree that current dementia care is inadequate, but they differ on whether the primary barrier is funding, political will, or scientific readiness.

Why it matters

Establishing a national waiting-time target for dementia could transform access to diagnosis and support for millions of people and their families. It would signal a shift in government priorities, potentially unlocking new funding and resources for a condition that currently lacks the structured care pathways seen in cancer. This move could also help address the growing burden on social care services and improve outcomes for an aging population.

What to watch

The government is expected to appoint a dedicated official to oversee dementia care and publish a modern service framework by the end of 2026. Baroness Louise Casey is set to release her recommendations on social care reform next summer, which will likely influence Burnham’s final decisions on funding and structural changes. The Alzheimer’s Society and The King’s Fund plan to continue their work, producing detailed recommendations on how to implement the proposed changes in the coming months.